Hi all,

This morning, Sherlock Bio announced that it has partnered with binx health to scale their rapid diagnostic COVID-19 test for point-of-care settings ranging from doctors’ offices to grocery stores. It’s the first FDA-authorized CRISPR point of care test that will come to market, and Sherlock CEO Rahul Dhanda shared with me the amazing story of how his team pivoted to apply its technology to the fight against COVID. Read it on Forbes here.

Yesterday, we had a great discussion on how to build a digital R&D backbone to improve the quality of data and products we make with biology. If you missed it, here’s the recording.

In a podcast with Microsoft’s Chief Technology Officer, Kevin Scott, synthetic biology pioneer Drew Endy explains how synthetic biology can be harnessed to solve some of today’s most pressing issues. Learn about Drew’s background, how he got into biology, and how the U.S.’s unique brand of bioeconomy can promote life, liberty, and the pursuit of happiness.

Finally, US-based food and agriculture biotech startup Boost Biomes and global crop nutrition company, Yara International ASA, announced the close of Boost’s $5 million series A equity round.

 

What’s coming up


The Global Synthetic Biology Conference 2020, September 1-3, 2020. Save the date and sign up for updates!

In funding news:

Cheers,
John

COVID-19 News

Latest News

Comparing 13 different CRISPR-Cas9 DNA scissors (Phys.org)

IDT launches gBlocks™ HiFi, improving on industry-leading products for synthetic biology (Press release)

Novozymes launches eco-friendly umami flavoring made with enzymes (Labiotech.eu)

The age of agrochemicals is ending: it’s time for agricultural biotechnology (Labiotech.eu)

Genetically modified rice could one day help keep your blood pressure down (BBC)

Using gene editing to keep cholesterol down and heart attacks at bay (Fierce Biotech)

Dotmatics acquires BioBright to accelerate laboratory data automation for the Lab of the Future (Press release)

Berkeley Lights announces Opto™ Antigen-Presenting Bead Kit to accelerate the expansion of antigen-specific T cells (Press release)

CAB lessons from California’s Built with Biology Summit

A year in, 1st patient to get gene editing for sickle cell disease is thriving (NPR)

CRISPR gene editing in human embryos wreaks chromosomal mayhem (Nature News)
 

Who's hiring?

Scientist, Analytical Chemistry (Physical Properties & Characterization): Geltor – San Leandro, CA

Senior Scientist, Analytical Chemistry: Geltor – San Leandro, CA

Scientist, Mammalian Cell Biology: Inscripta – Pleasanton, CA

Field Applications Scientist: Inscripta – Europe

Technology Development Engineer/Scientist: Inscripta – Boulder, CO

Senior Scientist, Biochemistry: Inscripta – Pleasanton, CA

Computational Biology Scientist: Inscripta – Boulder, CO

Research Manager: Novozymes – Davis, CA

Senior Scientist, Cell Biologist – Microbe: Inscripta, Boulder, CO

Field Applications Scientist – East: Inscripta, Boston, MA

Computational Scientist, Mammalian Bioinformatics: Inscripta, Pleasanton, CA

Account Executive: Inscripta – East Coast, United States
 

Feature your job here